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Abstract 
Biallelic mutations in NDUFAF6 have been identified as responsible for cases of autosomal recessive 
Leigh syndrome associated with mitochondrial complex I deficiency. Here, we report two siblings 
and two unrelated subjects with Leigh syndrome, in which we found the same compound 
heterozygous missense (c.532G>C:p.A178P) and deep intronic (c.420+784C>T) variants in NDUFAF6. 
We demonstrated that the identified intronic variant creates an alternative splice site, leading to 
production of an aberrant transcript.  
A detailed analysis of whole exome sequencing data together with functional validation based on 
mRNA analysis may reveal pathogenic variants even in non-exonic regions. 
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1. Introduction 
Leigh syndrome is an early onset progressive neurodegenerative disease with an invariably 
devastating clinical course. The neuropathology of Leigh syndrome is characterized by bilateral, 
symmetrical necrotic lesions in deep gray matter structures. The most common cause of Leigh 
syndrome is a defect in oxidative phosphorylation.1 The NADH dehydrogenase (ubiquinone) 
complex I assembly factor 6 (NDUFAF6, previously known as C8ORF38) gene encodes a 
mitochondrial protein, highly conserved across eukaryotes, which plays an essential role in the early 
assembly stages of mitochondrial respiratory chain complex I.2 Biallelic missense mutations within 
NDUFAF6 have been associated with cases of Leigh syndrome due to mitochondrial complex I 
deficiency.3-5 In a very recent paper about molecular and enzymatic assays for diagnosis in Leigh 
syndrome cases, NDUFAF6 was one of the most frequently mutated nuclear genes and was 
invariably associated with reduced complex I activity.6  
Recently, Bianciardi et al.7 described a patient presenting Leigh syndrome and mitochondrial 
complex I deficiency associated with a pathogenic heterozygous missense variant in NDUFAF6 
(c.532G>C:p.A178P) and an almost monoallelic expression of the mutated allele at transcriptional 
level; an autosomal recessive model of inheritance was hypothesized, but the second pathogenic 
mutation remained unidentified.7 Upon identification in our laboratory of two siblings and a 
singleton unrelated subject, all affected by Leigh syndrome and harbouring the same heterozygous 
missense mutation (c.532G>C:p.A178P), here we provide evidence that the second allelic mutation 
consists of a deep intronic variant present in all affected individuals, including the previously 
published case.7 Through mRNA analysis we demonstrated that the identified intronic mutation is 
responsible for the formation of an alternative splice site, leading to altered mRNA splicing. 
 
2. Materials and Methods 
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Informed consents for biological sample collection and genetic studies were obtained from all the 
subjects involved in the study (Siblings A1 and A2 and their parents; patient B, previously described 
by Bianciardi et al. 7; patient C and his parents), in agreement with the Declaration of Helsinki. 
Extraction of genomic DNA from peripheral blood was performed using standard methods. A 
targeted-NGS using a custom panel containing genes responsible for mitochondrial disorders8 was 
performed on DNAs from patients A1 and B, while clinical exome sequencing using a commercial kit 
with genes associated with inherited diseases (TrusightOne, Illumina) was performed in patient C. 
Whole exome sequencing (WES) analysis and variant calling/prioritization were conducted on DNAs 
from patients A1 and A2, as previously described.8 Libraries were prepared with the Nextera Rapid 
Exome Capture kit (Illumina), and sequencing was performed on an Illumina MiSeq platform. 
Variants identified by NGS were validated by Sanger sequencing and resolved on a 3130xl Genetic 
Analyzer (Applied Biosystems).  
The identified mutations were validated by employing the following pairs of primers, respectively: 
Exon 3b F: 5’-ATTTTGAGGTGGTGATTTCAAAG-3’; R: 5’- GGAAGGCTTTAGTGGTAAACTGG-3’; 
Exon 5 F: 5’-AATGGAAACCTATGGGCTAGAG-3’; R: 5’-TGAGCTTCTTGAAGTGGGATG-3’. 
For RNA purification and cDNA retrotranscription we used RNeasy mini kit (QIAGEN) and GoTaq 2-
Step RT-qPCR System (Promega), respectively, according to the manufacturers’ protocols. 
For cDNA amplification (from exon 3 to exon 7) and sequencing we used the following primer pair: 
3F: 5’-CTGAGAAAACAATTGGACTGATG-3’; 7R: 5’-TCTCACATTTTTATCTTGGTTCCTC-3’. 
For deep sequencing of NDUFAF6 transcript, PCR products were processed with Nextera XT DNA 
sample preparation kit (Illumina). Next Generation Sequencing (NGS) was performed on an Illumina 
MiSeq instrument. Filtered reads were then aligned using BWA and visualized with Integrating 
Genomics Viewer (IGV). 
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Tag SNPs were selected using the SNPinfo web server (https://snpinfo.niehs.nih.gov), based on the 
HapMap CEU (Utah residents with Northern and Western European ancestry) and Tuscani 
populations. Specific primers were designed (available upon request) and SNPs were assessed by 
Sanger sequencing. Information about SNPs frequencies was obtained from public databases: 
dbSNP, Genome Aggregation Database (gnomAD). 
For the nonsense-mediated mRNA decay (NMD) assay, patients and control fibroblasts were grown 
in complete DMEM and incubated for 12 h with puromycin (100 µg/ml). Total RNA was extracted 
after 4 and 8 hours of recovery in puromycin free medium from treated and untreated paired 
cultures. 
 
3. Results 
3.1. Case reports 
We report an Italian family in which two siblings were diagnosed with Leigh syndrome (Family A, 
Fig. 1A). The older sibling (patient A1) presented psychomotor regression at 21 months of age; 
neurological evaluation at 30 months showed ataxic gait and fine tremor. Cognitive functions were 
preserved. He presented a Leigh syndrome pattern at brain MRI. Biochemical analysis showed an 
isolated respiratory chain complex I deficiency in muscle and fibroblasts (42% and 38% of the 
controls’ mean, respectively; Suppl. Table S1). The disease was slowly progressive: at 4½ years he 
presented with drooling, dysarthria, dysmetria, tremor, severe ataxic gait and hypertonia. His 
younger sister (patient A2) showed psychomotor delay at the age of 12 months and then limb 
dysmetria, trunk titubation, and ataxic gait. Cognitive functions were preserved. MRI disclosed a 
Leigh syndrome pattern. Plasma lactate and pyruvate levels were slightly increased. A detailed 
clinical description of these cases is reported in the supplementary material. 
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Patient B was described in detail by Bianciardi et al.7 Briefly, he developed motor and language 
disturbances by the age of 3.5 years progressing to severe gait impairment, dysartria and early 
occurrence of dystonic movements. Brain MRI showed necrotic damage of the putamina, gradually 
extending to dentate nuclei and anterior caudate nuclei. Evaluation of mitochondrial respiratory 
chain revealed decreased complex I activity on fibroblasts (~25% of the controls’ mean), while 
enzymatic activity was normal on muscle homogenate (Suppl. Table S1). 
Patient C is an 11 year-old Italian boy, first child of unrelated parents. Psychomotor developmental 
milestones were referred as normal. He presented at 5 years of age with gait unsteadiness and 
motor coordination problems. These symptoms gradually worsened, configuring over time an 
extrapyramidal syndrome; cognitive function were preserved. Brain MRI disclosed involvement of 
the putamen bilaterally, stable over time. Extensive metabolic screening was normal as well as 
mtDNA analysis. A detailed clinical description of this case is reported in the supplementary 
material. 
3.2. Molecular studies 
WES was performed on patients A1 and A2. Variants annotation and filtering steps focused on 
variants shared by both siblings and affecting mitochondrial genes led to the identification of the 
heterozygous missense variant c.532G>C:p.A178P in NDUFAF6 (NM_152416.3) in both siblings; the 
same mutation (rs201088736) had been already reported as pathogenic by Bianciardi et al.7 Analysis 
of WES data also revealed the presence of an additional heterozygous intronic variant 
(NM_152416.3:c.420+784C>T) in NDUFAF6 in both affected siblings (Fig. 1A-B). It corresponds to 
rs749738738 in dbSNP database, and is reported with an extremely low allele frequency (0.003% in 
gnomAD). The missense and the intronic variants, validated by Sanger sequencing, were inherited 
from the unaffected father and mother, respectively (Fig. 1A).  
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In order to assess the effects of the intronic variant, RNA was extracted from fresh blood samples 
of family A members and retrotranscribed into cDNA. Through amplification and sequencing of the 
NDUFAF6 transcript (Fig. 1C-D), we detected an additional transcript in samples of both siblings and 
their mother (Suppl. Fig. S1): this corresponded to alternative splicing isoforms (e.g. 
ENST00000520757.1 or XM_005250791.1), retaining an extra 124 nucleotide-long exon (exon 3b; 
Fig. 1B) and predicted to undergo premature non-sense mediated decay on public databases, 
because of the creation of a premature stop codon. Interestingly, the alternative splicing acceptor 
site is placed 11 nucleotides downstream the rs749738738 variant and in silico predictions gave 
higher scores for creating an acceptor site to the mutant sequence (Suppl. Table S2).  
We also assessed and eventually confirmed the presence of the same intronic variant on DNA of patient B, 
already reported to be heterozygous for the paternally inherited c.532G>C:p.A178P mutation.7 In accordance 
with a recessive pattern of transmission, segregation analysis confirmed a maternal origin for the intronic 
variant. 
Similarly, direct sequencing revealed the c.420+784C>T intronic variant in an additional case, patient 
C, in which an independent genetic analysis using a clinical exome panel had identified the 
c.532G>C:p.A178P heterozygous variant. The two variants were inherited from the parents (Fig. 1). 
Increased expression of the alternative splicing isoform of the transcript (retaining exon 3b) was 
confirmed on RNA purified from patient B’s fibroblasts as well. 
A further analysis of NDUFAF6 transcripts using an NGS approach confirmed that, although 
expressed at low levels also in control subjects, the alternative isoform is overrepresented in the 
samples from individuals harboring the intronic variant (patients A1 and B, and the mother of 
siblings A1 and A2) compared to subjects lacking this variant (control subjects and the father of 
siblings A1 and A2) (Fig. 2).  
Notably, in the patients we observed a predominant expression of the mutated allele harboring the 
missense mutation c.532G>C in fibroblasts and, partly, in blood (Fig. 1D, Fig. 2). A non-sense 
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mediated decay (NMD) assay performed on fibroblasts from both patients A1 and B and a control 
individual did not show any detectable difference in RNA sequence profiles between treated and 
untreated samples.  
The identification of two extremely rare variants in three unrelated families from Italy displaying a 
similar clinical presentation raised the possibility of unreported/unknown relationship between the 
families and common founder alleles. All the families originate from Southern Italy, although from 
different regions (2 from Campania, 1 from Abruzzo). We performed a haplotype analysis using 7 
tagSNPs present in the NDUFAF6 genomic region. All the patients showed the same haplotype 
(Suppl. Table S3) indicating that they likely harbor common NDUFAF6 alleles rather than having had 
independent mutational events. Analysis of the variants identified by targeted-NGS confirmed this 
finding, with shared NDUFAF6 haplotypes amongst patients; however it revealed a quite different 
variants profile in surrounding genes present on chromosome 8 (Suppl. Table S4), suggesting not 
recent founder occurrence.  
4. Discussion 
We identified compound heterozygous missense and deep intronic variants in three different 
families with a typical recessive NDUFAF6-related disease characterized by Leigh syndrome. 
Complementation studies, previously performed on patient B,7 already proved that NDUFAF6 
impairment was the cause of the disease. In accordance with in silico predictions, our transcript data 
suggest that the intronic variant promotes the alternative splicing event, thus enhancing expression 
of the non-functional altered isoform of the gene at the expense of the canonical one. 
An NMD assay, together with the amplification of the aberrant transcript in standard conditions, 
excludes the hypothesis of a relevant NMD involvement on the alternative NDUFAF6 isoform, at 
least in fibroblasts. Nevertheless, several NDUFAF6 transcripts which could be variably expressed in 
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different tissues have been reported2 and may be differently affected by the intronic variant and 
otherwise subjected to NMD. 
In line with our data, Bianciardi et al, have previously  shown an almost exclusive expression of the 
missense exonic mutation in blood and fibroblasts-derived RNA samples from Patient B in 
comparison with urine and brush RNA samples which showed a heterozygous expression for this 
variant. These data could thus suggest the existence of trans-splicing factors which determine a 
tissue-specific  switch  between the alternative spliced isoform and the canonical isoform, with the 
alternative spliced isoform being highly expressed in tissues such as blood and fibroblasts rather 
than urotelium (Figure 3). According to this hypothesis,  in  blood and fibroblasts from our patients, 
due to the presence of the intronic variant,  the predominant  inclusion of an alternative exon in 
about a 50% of the total transcript would lead to a highly unstable not detectable isoform  and 
consequently to the apparent homozygous expression of the missense exonic mutation.  The fact 
that we identified three unrelated cases with the same, peculiar combination of extremely rare 
NDUFAF6 variants may be casual. Otherwise we may speculate that one of these variants is 
hypomorphic (possibly the splicing variant which allows the formation of a quote of wild type 
transcript) and does not lead to disease, at least Leigh syndrome, in the homozygous state but only 
when associated with a severe mutation which in turn is too deleterious/embryolethal in the 
homozygous state. Homozygosity or various compound heterozygosity of splicing defect, missense 
changes or nonsense mutations have been found in the previously reported patients with NDUFAF6 
mutations3-6, and the affected nucleotides are located throughout the gene hampering an easy 
identification of obvious genotype-phenotype correlations. 
The clinical presentation of the NDUFAF6-mutant cases here reported is a Leigh syndrome with early 
childhood onset (1-5 years) and stable or slowly progressive course, associated with isolated 
cerebellar or extrapyramidal signs depending on affected cerebral structures; cognitive involvement 
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and seizures were not detected/reported. MRI pattern was characterized by striatal and dentate 
nuclei involvement. Patient C presented isolated putamina involvement that was stable over time, 
and a relatively mild phenotype compared to other patients. Only in patient A2 putamen alterations 
were not observed, but she performed a single MRI at disease onset and additional data about 
radiological course were not available.  
Reports on mutations located outside the coding regions and associated with human diseases are 
rapidly growing. In this study we confirmed that WES data analysis should take into account all rare 
variants, including those with poorly predictable effect on transcript/protein. Moreover we 
underline that mRNA analysis is a complementary strategy, extremely useful to integrate WES and 
demonstrate the deleterious impact of identified variants, especially those affecting splicing and 
stability of transcripts. 
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Figure Legends 
 
Figure 1. Pedigrees and genetic studies 
A. Pedigrees of the families A, B, C showing the identified NDUFAF6 variants. Black symbols indicate 
the affected siblings. 
B. Schematic structure of NDUFAF6 NM_152416.3 transcript (upper panel) and alternative splicing 
isoform (bottom panel). The retention of a string of 124 nucleotides located within intron 3 (exon 
3b, orange box) generates a premature stop codon within exon 4 (arrow). 
C. Sanger sequence of NDUFAF6 cDNA obtained from patient A1 blood RNA, showing two distinct 
sequences starting from the end of exon 3, that correspond to the NM_152416.3 transcript (junction 
exon 3-exon 4) and an alternative transcript retaining exon 3b (junction exon 3-exon 3b). 
D. Sanger sequence of NDUFAF6 cDNA obtained from blood samples of patient A1 (bottom panel) 
and his father (I-1, upper panel), showing a region within exon 5 which encompasses the 
heterozygous missense mutation. 
 
Figure 2. NGS coverage analysis 
A. Profiles of depth of coverage obtained through NGS on NDUFAF6 transcript PCR products. RNA 
was extracted from lymphocytes of Patient A1 (Pt. A1) and his parents (I-1; I-2), and from fibroblasts 
of patients A1, B and a control sample (CTR). 
B. Quantification of exon 3b retention. Graphs of the coverage ratio (in percentage) between the 
NDUFAF6 alternative isoform containing exon 3b and the canonical isoform, calculated for all the 
samples analyzed by NGS (the two bars correspond to the junctions exon 3-exon 3b and exon 3b-
exon 4). 
 
14 
 
 
Figure 1 
 
15 
 
 
Figure 2 
 
